JERUSALEM, November 8, 2016 /PRNewswire/ -- BRH Medical announced today that the USA and China issued patents for its innovative wound healing system for the treatment of Diabetic Leg Wounds, Venous Leg Ulcers, and Pressure Ulcers. The patent issued in China covers the treatment of skin ulcers, while the patent issued by the US Patent and Trademark Office covers both the technology developed for treatment of skin ulcers and the advanced documentation technology integrated into the system. "Patents in both of these markets highlight the uniqueness of our wound healing product," said Motti Oderberg, CEO, BRH Medical. "Both the USA and China have a very large market potential and achieving patents in these countries represent an important stage in the penetration of these markets," Oderberg added. The BRH wound treatment solution is based on ultrasound and electric fields integrated in one system. Each system is equipped with a built-in digital photo measurement assembly as well as documentation software for tracking the wound healing progress. Ilan Feferberg, BRH Medical Chief Technology Officer and the inventor behind the patented technology explained, "It has always been my desire to develop a product that would truly help to cure people. Our grateful patients are proof of the effectiveness of the technology." The system has been clinically proven to reduce wound pain as well as accelerate wound healing. A published study-related paper showed that after only one month of treatments, more than 50% of the Diabetic Foot Ulcers responded positively and resulted in wound closure. Mr. Oderberg concluded, "The market for wound healing products is large and growing and vision is to become the gold standard for treatment of chronic wounds of all kinds, including pressure wounds, diabetic leg wounds and wounds caused as a result of ischemia."